The Role of LRRK2 in Neurodegeneration of Parkinson Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|16|9|1348-1357

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.16, Iss.9, 2018-11, pp. : 1348-1357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Iron in Neurodegeneration: Prospects for Pharmacotherapy of Parkinson's Disease

By Jellinger K.A.  

Drugs & Aging, Vol. 14, Iss. 2, 1999-02 ,pp. : 115-140

Adis International

Access to resources Recommend Favorite

Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat

By Barthwal M.K.   Srivastava N.   Dikshit M.  

Redox Report, Vol. 6, Iss. 5, 2001-10 ,pp. : 297-302

Maney Publishing

Access to resources Recommend Favorite

Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-05 ,pp. : 927-938

Bentham Science Publishers

Access to resources Recommend Favorite

The Paths to Neurodegeneration in Genetic Parkinson's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 9, 2014-11 ,pp. : 1485-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease

By Singh Sarika   Das T.   Ravindran A.   Chaturvedi R.K.   Shukla Y.   Agarwal A.K.   Dikshit M.  

Redox Report, Vol. 10, Iss. 2, 2005-04 ,pp. : 103-109

Maney Publishing

Access to resources Recommend Favorite